Antithymocyte-globulin/ciclosporinNo response: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1888卷 / 1期

关键词：

D O I：

10.1007/s40278-022-08413-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：71 / 71

相关论文

共 50 条

[31] Antithymocyte-globulin/eculizumabLack of efficacy: case report
Reactions Weekly, 2025, 2043 (1) : 48 - 48
[32] Antithymocyte-globulin/tocilizumabLack of efficacy: case report
Reactions Weekly, 2023, 1970 (1) : 43 - 43
[33] Antithymocyte-globulin/busulfan/fludarabineMelanoderma: case report
Reactions Weekly, 2017, 1644 (1) : 38 - 38
[34] Antithymocyte-globulin/plasmaVarious toxicities: case report
Reactions Weekly, 2023, 1938 (1) : 210 - 210
[35] Antithymocyte-globulin/eltrombopagLack of efficacy: case report
Reactions Weekly, 2022, 1909 (1) : 85 - 85
[36] Antithymocyte-globulin/cyclophosphamideCongestive heart failure and capillary leak syndrome: 2 case reports
Reactions Weekly, 2020, 1797 (1) : 42 - 42
[37] Antithymocyte-globulin/ciclosporin/tacrolimusMild allergic reaction, hepatitis and exanthema: 3 case reports
Reactions Weekly, 2024, 2031 (1) : 51 - 51
[38] Alemtuzumab/antithymocyte-globulin/methylprednisolonePulmonary nocardiosis: case report
Reactions Weekly, 2015, 1573 (1) : 25 - 25
[39] Antithymocyte-globulin/Busulfan/FludarabineLack of efficacy: case report
Reactions Weekly, 2024, 2038 (1) : 30 - 30
[40] Antithymocyte-globulin/eculizumabLack of efficacy
Reactions Weekly, 2024, 2012 (1) : 50 - 50

← 1 2 3 4 5 →